Skip navigation | ||
|
||
Medical Encyclopedia |
|
Other encyclopedia topics: | A-Ag Ah-Ap Aq-Az B-Bk Bl-Bz C-Cg Ch-Co Cp-Cz D-Di Dj-Dz E-Ep Eq-Ez F G H-Hf Hg-Hz I-In Io-Iz J K L-Ln Lo-Lz M-Mf Mg-Mz N O P-Pl Pm-Pz Q R S-Sh Si-Sp Sq-Sz T-Tn To-Tz U V W X Y Z 0-9 |
Contents of this page: | |
|
|
|
Definition Return to top
Breast milk jaundice is persistent jaundice in the newborn, caused by certain enzyme inhibitors found in the breast milk. It occurs after the first week of life and may continue up to the sixth week of life in otherwise healthy and exclusively breast-fed infants.Causes, incidence, and risk factors Return to top
Jaundice is a yellowish tinge to the skin and/or eyes. Jaundice in a newborn (neonatal jaundice) is a common and normal occurrence caused by excess bilirubin (a breakdown product of hemoglobin made by the liver).
All babies have some degree of jaundice. Breast-fed babies often have more severe jaundice. This is known as "breast feeding jaundice." While there is no scientific proof, some experts think this exaggerated jaundice provides the baby with antioxidant effects, protecting the infant from tissue injury or disease.
If the jaundice occurs or persists past the first week in an otherwise healthy and thriving breast-fed infant, this condition is called "breast milk jaundice." The cause is thought to relate to factors in the breast milk itself which inhibit certain enzymes in the liver.
Breast milk jaundice does tend to run in families. It is seen equally in males and females and affects approximately 0.5% to 2.4% of live births.
Symptoms Return to top
The symptom is prolonged jaundice in a healthy, breast-fed newborn, beginning after the first week of life and continuing up to the sixth week of life.
Signs and tests Return to top
Treatment Return to top
Treatment will depend on the bilirubin level. In general, more frequent nursing (up to 12 times a day) will decrease the bilirubin level. If the bilirubin level is worrisome (greater than 20 mg/dL), a mother can stop nursing for 24 to 48 hours, which will result in a rapid drop of bilirubin.
She can express the milk or pump her breasts (to maintain comfort and the flow of milk) and bottle feed the baby in the interim. When nursing is re-started, the bilirubin will not return to previous levels. Other measures, such as phototherapy, may be necessary with bilirubin levels greater than18 mg/dL (or if bilirubin levels are lower but rapidly increasing).
Expectations (prognosis) Return to top
Full recovery is expected with appropriate monitoring and treatment.Complications Return to top
There are usually no complications with appropriate monitoring and treatment. However, failure to obtain timely and proper medical care can have severe consequences. High bilirubin levels can be toxic to the baby's brain and other organs.Calling your health care provider Return to top
Call your health care provider immediately if you are breast feeding your baby and the baby becomes yellow (jaundiced).Prevention Return to top
Breast milk jaundice is not preventable. When the condition does occur, it is very important to recognize that your baby looks yellow as early as possible, and to have bilirubin levels checked right away to make sure that there are no other liver problems.
Breast feeding jaundice (which occurs during the first week of life) can be limited by making sure your baby is getting enough breast milk. Give your baby unlimited time at each breast, and feed approximately 10 to 12 times per day starting from the first day of life. Get help from a lactation consultant or your doctor as soon as possible if you experience any difficulty.
Update Date: 1/13/2003 Updated by: Jonathan Fanaroff, M.D., Department of Pediatrics, Rainbow Babies and Children's Hospital, Case Western Reserve University, Cleveland, OH. Review provided by VeriMed Healthcare Network.
Home | Health Topics | Drug Information | Encyclopedia | Dictionary | News | Directories | Other Resources | |
Copyright | Privacy | Accessibility | Selection Guidelines U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894 National Institutes of Health | Department of Health & Human Services |
Page last updated: 28 October 2004 |